Scarica l'app Stockscreener
7.08
6.84%
-0.52
Dopo l'orario di chiusura:
7.01
-0.07
-0.99%
Precedente Chiudi:
$7.60
Aprire:
$7.6
Volume 24 ore:
124.24K
Relative Volume:
0.38
Capitalizzazione di mercato:
$65.51M
Reddito:
-
Utile/perdita netta:
$-6.42M
Rapporto P/E:
-1.264
EPS:
-5.6013
Flusso di cassa netto:
$-7.45M
1 W Prestazione:
-13.13%
1M Prestazione:
-9.11%
6M Prestazione:
-27.76%
1 anno Prestazione:
-49.61%
Intervallo 1D:
$7.03
$7.6199
Intervallo di 1 settimana:
$7.03
$8.39
Portata 52W:
$1.80
$16.94
Cervomed Inc Stock (CRVO) Company Profile
Nome
Cervomed Inc
Settore
Industria
Telefono
(617) 744-4400
Indirizzo
20 PARK PLAZA, BOSTON
Confronta CRVO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRVO
Cervomed Inc
|
7.08 | 70.32M | 0 | -6.42M | -7.45M | -5.6013 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Cervomed Inc Stock (CRVO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-13 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2024-12-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-12-11 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2024-12-11 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2024-12-10 | Downgrade | D. Boral Capital | Buy → Hold |
| 2024-12-06 | Iniziato | ROTH MKM | Buy |
| 2024-12-05 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-18 | Iniziato | Chardan Capital Markets | Buy |
| 2024-07-26 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-15 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2018-03-21 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Cervomed Inc Borsa (CRVO) Ultime notizie
What hedge fund activity signals for CervoMed Inc. stockMarket Sentiment Summary & Weekly Top Gainers Alerts - Trung tâm Dự báo KTTV quốc gia
S P Trends: Can CervoMed Inc. stock attract ESG capital inflowsShare Buyback & Accurate Buy Signal Notifications - Trung tâm Dự báo KTTV quốc gia
Setup Watch: How CervoMed Inc. stock benefits from strong dollar2025 Market Outlook & Accurate Buy Signal Notifications - Trung tâm Dự báo KTTV quốc gia
Institution Moves: Does CervoMed Inc. stock trade at a discount to peersJuly 2025 Weekly Recap & Weekly Stock Breakout Alerts - Trung tâm Dự báo KTTV quốc gia
CervoMed (NASDAQ:CRVO) Cut to “Strong Sell” at Zacks Research - Defense World
Trend analysis for CervoMed Inc. this weekPortfolio Return Report & Free Accurate Trade Setup Notifications - newser.com
Will CervoMed Inc. stock reach all time highs in 2025July 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Custom watchlist performance reports with CervoMed Inc.July 2025 Sector Moves & Weekly Market Pulse Updates - newser.com
Will CervoMed Inc. outperform the market2025 Market Trends & Safe Swing Trade Setups - newser.com
How to interpret RSI for CervoMed Inc. stockPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - newser.com
Will CervoMed Inc. (DP8) stock keep high P E multiplesJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
Is CervoMed Inc. a candidate for recovery playQuarterly Trade Review & Capital Efficient Trading Techniques - newser.com
Statistical indicators supporting CervoMed Inc.’s strengthJuly 2025 EndofMonth & Real-Time Market Sentiment Alerts - newser.com
Analyzing recovery setups for CervoMed Inc. investors2025 Risk Factors & AI Based Trade Execution Alerts - newser.com
What to do if you’re stuck in CervoMed Inc.2025 Momentum Check & Community Supported Trade Ideas - newser.com
Does CervoMed Inc. stock trade at a discount to peersIPO Watch & Advanced Swing Trade Entry Plans - newser.com
Using data tools to time your CervoMed Inc. exitJuly 2025 Selloffs & High Yield Equity Trading Tips - newser.com
Advanced analytics toolkit walkthrough for CervoMed Inc.2025 Geopolitical Influence & Long Hold Capital Preservation Plans - newser.com
CervoMed (NASDAQ:CRVO) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Why CervoMed Inc. stock is rated strong buyShare Buyback & Low Drawdown Momentum Ideas - newser.com
CervoMed Unveils Promising Phase 2b Trial Results - TipRanks
CervoMed Drug Cut Dementia Progression Risk By 75% In Trial - inkl
CervoMed shares jump after strong results in dementia drug trial - MSN
CervoMed stock jumps after new positive dementia drug results - Business Upturn
CervoMed stock soars after positive dementia treatment trial data By Investing.com - Investing.com South Africa
CervoMed stock soars after positive dementia treatment trial data - Investing.com
CervoMed Says Neflamapimod Shows Effective in Treating Dementia with Lewy Bodies Without Alzheimer's Overlap - MarketScreener
CervoMed (CRVO) Reveals Promising Phase 2b Trial Data for Dement - GuruFocus
CervoMed rises after dementia drug shows promise in mid-stage study - TradingView
CervoMed Inc. Reports Promising Phase 2b Trial Results for Neflamapimod in Dementia with Lewy Bodies - Quiver Quantitative
1.12‑pt CDR‑SB gain; 50% GFAP drop — CervoMed Phase 2b RewinD‑LB data show clinical–biomarker correlation - Stock Titan
CervoMed appoints Matthew Winton as chief commercial and business officer By Investing.com - Investing.com Canada
CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer - GlobeNewswire
CervoMed Inc. Appoints Matthew Winton as Chief Commercial and Business Officer - MarketScreener
CervoMed appoints Matthew Winton as chief commercial and business officer - Investing.com
Cervomed Inc Azioni (CRVO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):